COVID-19 Update: Therapies and Vaccines


COVID-19 Update with Dr. Paul Auwaerter

Dr. Paul Auwaerter – Professor of Medicine at Johns Hopkins University School of Medicine – reviews the latest on COVID-19 transmission, therapy, and vaccination, hosted by Dr. Bill Detmer, CEO of Unbound Medicine.

VIDEO Watch COVID-19 December Update on YouTube

YouTube video.

PODCAST Insights in Healthcare Education Podcast | Unbound Medicine

Insights in Healthcare Education from Unbound Medicine





Update on COVID-19 transmission and mortality


COVID-19 general approach to therapy (Dexamethasone, Remdesivir)


Antibody-Based Therapies (Bamlanivimab, Casirivimab + Imdevimab - Regeneron cocktail)


Convalescent Plasma (Low and High Titer)


Immunomodulators: Tocilizumab, Baricitinib + Remdesivir


Vaccines: mRNA vaccines (BioNTech/Pfizer, Moderna): efficacy and side effects



Can COVID-19 vaccines cause adverse immune responses?


If you’ve had COVID, should you get the vaccine?


Demographics of participants in COVID vaccine clinical trials: how well are groups represented?


Children: when will we know whether and how they should be vaccinated?


Vaccine distribution: does everyone need two doses?


Vaccine distribution: who will get first priority and why?


Vaccine immunity: how long is it likely to last?


Wrap up, thanks, and conclusions


1-minute feedback survey

About the Presenters

Paul Auwaerter, MD, MBA

JHU Auwaerter

Paul G. Auwaerter is the Sherrilyn and Ken Fisher Professor of Medicine at the Johns Hopkins University School of Medicine serving as the Clinical Director for the Division of Infectious Diseases and Director of the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases.

He serves as the Executive Director of the Johns Hopkins Point of Care-Information Technology (POC-IT) Center producing the Johns Hopkins Guides – Antibiotic (ABX) (Antibiotic), HIV, Osler, Psychiatry and Diabetes Guides. In 2018, Dr. Auwaerter served as President for the Infectious Diseases Society of America, the largest professional society worldwide related to infectious diseases.

William M. Detmer, MD, MSc

Unbound Medicine Detmer

Bill Detmer is CEO of Unbound Medicine. He entered medical school at UC-San Francisco the year the first Macintosh computer was launched and soon found himself using it to organize the reams of basic science and clinical knowledge he needed to learn. That led to a career-long pursuit to solve the "knowledge problem” in healthcare – despite the wide availability of high-quality medical information and advanced technologies for delivery, two-thirds of questions that arise in daily clinical practice are never answered.

Bill’s pursuit of knowledge solutions has traversed becoming a general internist and faculty member at UCSF, completing training at Stanford in the nascent field of medical informatics, developing the first web-based search interface to the world’s medical literature and commercializing it with Ovid Technologies, and starting Unbound Medicine 21 years ago. Today, Unbound Medicine partners with medical and nursing associations, 500+ healthcare institutions, and over 6 million health professionals worldwide to deliver knowledge where and when it is needed on the user’s device of choice.

See Also

COVID-19 Update: Therapies and Vaccines is a sample topic from the Message Center - Hopkins Guides.

To view other topics, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. .

Last updated: January 7, 2021